We asked five of our Novartis scientists a simple question: how many different types of cancer can you name? It turns out the answer is not so simple. Cancer isn’t one disease but a dizzying array of types and subtypes with different causes and characteristics. Embracing this complexity is key to helping solve cancer. At Novartis, we’re committed to unraveling the inner workings of cancer and to building as broad and deep a toolbox of approaches as we can. It’s why we we’re working to develop new therapies for a vast range of cancers, both common and rare; why we’re investing in diverse technology platforms and experimenting with combination approaches; why we’re pursuing powerful new tools like artificial intelligence, and much more. Learn more: https://bit.ly/3fYShD1 ©2022 Novartis AG

 3150      20